Institutions / Deep Track Capital, LP / Holdings
Back to Deep Track Capital, LP

Deep Track Capital, LP

All holdings · as of Dec 31, 2025

53 positions

CompanyClassValueShares% of portfolio
Immunovant, Inc.IMVTCommon Stock$293.02M11,526,9716.7%
Guardant Health, Inc.—$285.99M2,800,0006.5%
Structure Therapeutics Inc.GPCRADR$285.97M4,111,7826.5%
TARSUS PHARMACEUTICALS, INC.—$245.97M3,004,0345.6%
DYNAVAX TECHNOLOGIES CORP—$241.87M15,726,3495.5%
Cytokinetics Inc—$212.03M3,336,9984.8%
Axsome Therapeutics, Inc.—$210.04M1,150,0004.8%
Apellis Pharmaceuticals, Inc.—$194.68M7,750,0004.4%
VAXCYTE, INC.—$184.56M4,000,0004.2%
Maze Therapeutics, Inc.—$175.93M4,246,4404.0%
Vera Therapeutics, Inc.—$142.86M2,821,1353.3%
BioMarin Pharmaceutical Inc—$136.69M2,300,0003.1%
IONIS PHARMACEUTICALS INC—$134.49M1,700,0003.1%
Nurix Therapeutics, Inc.—$133.48M7,036,4553.0%
MBX Biosciences, Inc.MBXCommon Stock$102.50M3,249,7902.3%
Ocular Therapeutix, Inc—$97.97M8,070,4142.2%
GRAIL, Inc.—$87.54M1,022,7972.0%
Viridian Therapeutics, Inc.—$78.57M2,524,8331.8%
LB PHARMACEUTICALS INCLBRXCommon Stock$74.63M3,352,8041.7%
IMMUNOCORE HOLDINGS PLC-ADRIMCRADR$69.56M2,003,9781.6%
Oruka Therapeutics, Inc.—$65.52M2,161,5101.5%
BridgeBio Pharma, Inc.—$61.97M810,1421.4%
CorMedix Inc.—$61.34M5,274,0761.4%
MoonLake ImmunotherapeuticsMLTXCommon Stock$60.76M4,610,0711.4%
Alkermes plc.—$55.96M2,000,0001.3%
Dyne Therapeutics, Inc.—$51.83M2,650,0001.2%
Celldex Therapeutics, Inc.—$51.62M1,900,7381.2%
COMPASS Pathways plcCMPSADR$50.61M7,334,3231.2%
CENTESSA PHARMACEUTICALS PLC—$50.02M2,000,0001.1%
SOLENO THERAPEUTICS, INC.—$46.30M1,000,0001.1%
Verastem, Inc.—$44.32M5,740,8501.0%
Bicara Therapeutics Inc.—$43.99M2,614,0041.0%
GERON CORP—$42.91M32,511,2711.0%
enGene Therapeutics Inc.—$39.53M4,377,5720.9%
ANI PHARMACEUTICALS INC—$37.71M477,6840.9%
Terns Pharmaceuticals, Inc.—$31.07M769,0480.7%
ENANTA PHARMACEUTICALS INC—$30.86M1,956,8670.7%
MIND MEDICINE MINDMED INC—$22.45M1,676,5400.5%
Tango Therapeutics, Inc.—$21.75M2,454,5620.5%
X4 Pharmaceuticals, Inc—$20.05M5,013,6610.5%
ATAI BECKLEY NV—$19.13M4,677,2890.4%
Xenon Pharmaceuticals Inc.—$16.42M366,4350.4%
Cogent Biosciences, Inc.—$16.09M453,1020.4%
Cybin Inc.—$15.17M1,854,2550.3%
Context Therapeutics Inc.—$10.91M7,419,3550.2%
Monopar Therapeutics Inc.MNPRCommon Stock$6.23M95,4080.1%
CRESCENT BIOPHARMA, INC.—$5.38M453,6860.1%
Aligos Therapeutics, Inc.—$4.14M444,1100.1%
BillionToOne, Inc.BLLNCommon Stock$4.09M50,0000.1%
RAPT THERAPEUTICS INC—$3.74M110,4480.1%
← PrevPage 1 of 2Next →